Effect of LDL-apheresis on the pharmacokinetics of the lipophilic antilipidemic agent probucol

European Journal of Drug Metabolism and Pharmacokinetics

Volumn 22, Issue 3, 1997, Pages 201-206

  Komura, T ^b   Takahara, K ^a   Sugano, M ^b   Fujinishi, A ^b   Tasaki, H ^b   Nakashima, Y ^b   Kuroiwa, A ^b  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b NONE

Author keywords

Apheresis; Low density lipoprotein (LDL); Probucol

Indexed keywords

ANTILIPEMIC AGENT; CHOLESTEROL; DEXTRAN SULFATE; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PROBUCOL;

APHERESIS; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIPOPROTEIN BLOOD LEVEL; MALE;

EID: 0030689629     PISSN: 03787966     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03189807     Document Type: Article

References (11)

1. Yokoyama S., Hayashi R., Kikkawa T. et al. (1984) : Specific sorbent of apolipoprotein B-containing lipoproteins for plasmapheresis. Characterization and experimental use in hypercholesterolemic rabbits. Arteriosclerosis, 4, 276-282.
2. Yokoyama S., Hayashi R., Satani M., Yamamoto A. (1985) : Selective removal of low density lipoprotein by plasmapheresis in familial hypercholesterolemia. Arteriosclerosis, 5, 613-622.
3. Gordon B.R., Kelsey S.F., Biheimer D.W. et al. (1992) : Treatment of refractory familial hypercholesterolemia by low-density-lipoprotein apheresis using an automated dextran sulfate cellulose adsorption system. Am. J. Cardiol., 70, 1010-1016.
4. Barnhart J.W., Sefranka J.A., McIntosh D.D. (1970) : Hypocholesterolemic effect of 4,4′(isopropylidenedithio)-bis-(2, 6-bi-t-butylphenol). Am. J. Clin. Nutr., 23, 1229-1233.
5. Knipping G., Rtheneder M., Striegl G., Esterbauer H. (1990) : Antioxidants and resistance against oxidation of porcine LDL subfractions. J. Lipid Res., 31, 1965-1972.
6. Esterbauer H., Rotheneder M.D., Striegl G., Waeg G. (1991) : Role of vitamin E in preventing the oxidation of low density lipoprotein. Am. J. Clin. Nutr., 61, 314S-321S.
7. Urien S., Riant P., Albengres E., Brioude R., Tillement J-P. (1984) : In vitro studies on the distribution of probucol among human plasma lipoproteins: Mol. Pharmacol., 26, 322-327.
8. Takegoshi T., Sudo K., Midorikawa K. (1983) : Studies on the distribution of probucol in human serum lipoprotein fractions (in Japanese). J. Jpn. Atheroscler. Soc., 10, 113.
9. Sudo K., Midorikawa K., Tachizawa H. (1983) : Studies on the distribution of probucol in human serum lipoprotein fractions (part II) (in Japanese). J. Jpn. Atheroscler. Soc., 11, 591.
10. Naruszewicz M., Carew T.E., Pittman R.C., Witztum J.L., Steinberg D. (1984) : A novel mechanism by which probucol lowers low density lipoprotein levels demonstrated in the LDL receptor deficient rabbit. J. Lipid Res., 25, 1206-1213.
11. Kita T., Nagano Y., Yokode M. et al. (1987) : Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia. Proc. Natl. Acad. Sci. USA, 84, 5928-5931.